Applied DNA COVID-19 Assay Kit Can Detect Multiple SARS-CoV-2 Variants

 - Confirms Assay Kits’ Value in Tracking New SARS-CoV-2 Variants in Surveillance and Diagnostic Testing -

- Vast Majority of PCR and Antigen Testing Unable to Detect Currently Known Variants -

- Multiple-Targets Assay Design Provides for Positive Results for Infected Individuals, while S-Gene "Dropout" Signals the Presence of a Variant –

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Linea™ COVID-19 Assay Kit (the "Assay Kit") identified COVID-19 positive samples that are variants distinct from the wild-type virus that has dominated the U.S. in the pandemic until now. The variants were identified as part of the Company’s safeCircleTM pooled surveillance testing service, which is powered by the Company’s Assay Kits. The Assay Kits are also available for diagnostic use in third-party laboratories certified for complex molecular diagnostics.

https://finance.yahoo.com/news/applied-dna-linea-covid-19-120000335.html